Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Strides Pharma Science Ltd.
( in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]4391.683891.023607.673022.063251.16
Other Operating Revenues173.65160.1080.7248.1964.72
Total Operating Revenues4565.344051.123688.393070.253315.87
      
Other Income58.7239.7090.33131.9951.43
Total Revenue4624.064090.833778.723202.243367.30
      
EXPENSES     
Cost Of Materials Consumed1475.891341.111441.681090.931390.42
Purchase Of Stock-In Trade688.08283.45187.87316.11296.08
Changes In Inventories Of FG,WIP And Stock-In Trade-184.0115.94-2.6795.28-353.71
Employee Benefit Expenses862.76751.13732.02646.91550.15
Finance Costs248.85314.45261.14176.74150.07
Depreciation And Amortisation Expenses192.26220.68243.25233.01206.29
Other Expenses919.80916.23899.30941.13798.10
Total Expenses4203.633842.993762.603500.113037.39
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax420.42247.8416.12-297.88329.91
      
Exceptional Items64.66-189.05-17.03-243.8343.35
Profit/Loss Before Tax485.0858.79-0.92-541.70373.26
      
Tax Expenses-Continued Operations     
Current Tax46.9137.31-31.70-150.4421.45
Deferred Tax30.61-5.72-23.60-27.8210.20
Total Tax Expenses77.5231.59-55.30-178.2631.65
Profit/Loss After Tax And Before ExtraOrdinary Items407.5727.2054.38-363.44341.61
      
Profit/Loss From Continuing Operations407.5727.2054.38-363.44341.61
      
Profit/Loss From Discontinuing Operations3188.1154.2218.570.0013.94
Net Profit/Loss From Discontinuing Operations3188.1154.2218.570.0013.94
Profit/Loss For The Period3595.6881.4272.95-363.44355.55
      
Minority Interest-4.0623.709.7014.0410.71
Share Of Profit/Loss Of Associates1.84-175.74-285.28-110.81-97.82
Consolidated Profit/Loss After MI And Associates3593.46-70.61-202.64-460.21268.44
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)390.55-7.76-22.49-51.2829.96
Diluted EPS (Rs.)390.50-7.76-22.49-51.2829.92
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend22.9913.550.000.0017.92
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]4391.68
Other Operating Revenues173.65
Total Operating Revenues4565.34
Other Income58.72
Total Revenue4624.06
EXPENSES 
Cost Of Materials Consumed1475.89
Purchase Of Stock-In Trade688.08
Changes In Inventories Of FG,WIP And Stock-In Trade-184.01
Employee Benefit Expenses862.76
Finance Costs248.85
Depreciation And Amortisation Expenses192.26
Other Expenses919.80
Total Expenses4203.63
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax420.42
Exceptional Items64.66
Profit/Loss Before Tax485.08
Tax Expenses-Continued Operations 
Current Tax46.91
Deferred Tax30.61
Total Tax Expenses77.52
Profit/Loss After Tax And Before ExtraOrdinary Items407.57
Profit/Loss From Continuing Operations407.57
Profit/Loss From Discontinuing Operations3188.11
Net Profit/Loss From Discontinuing Operations3188.11
Profit/Loss For The Period3595.68
Minority Interest-4.06
Share Of Profit/Loss Of Associates1.84
Consolidated Profit/Loss After MI And Associates3593.46
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)390.55
Diluted EPS (Rs.)390.50
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend22.99